Coordination in gene expression during atherogenesis

[1]  A. Orekhov,et al.  Changes in levels of gene expression in human aortal intima during atherogenesis , 2013, Biochemistry (Moscow).

[2]  上田 高志,et al.  Arterioscler Thromb Vasc Biol誌掲載論文 強い生理的光曝露によるPGC-1αを介したVEGF発現上昇と脈絡膜新生血管の増強作用 (日本人のヒット論文 : 本音で語る苦労話(第2回)) , 2013 .

[3]  W. Cullen,et al.  Research confuses me: what is the difference between case-control and cohort studies in quantitative research? , 2013, Irish medical journal.

[4]  E. Topol,et al.  Comparative gene expression analysis between coronary arteries and internal mammary arteries identifies a role for the TES gene in endothelial cell functions relevant to coronary artery disease. , 2012, Human molecular genetics.

[5]  M. Alegret,et al.  Regulation of gene expression in atherosclerosis: insights from microarray studies in monocytes/macrophages. , 2012, Pharmacogenomics.

[6]  Sunghee Cho.  CD36 as a therapeutic target for endothelial dysfunction in stroke. , 2012, Current pharmaceutical design.

[7]  T. Lehtimäki,et al.  Proprotein convertases in human atherosclerotic plaques: the overexpression of FURIN and its substrate cytokines BAFF and APRIL. , 2011, Atherosclerosis.

[8]  A. Orekhov,et al.  Contents of mRNAs encoding endosome/lysosome components in normal human aorta and in stage ii of atherogenesis: a hidden regulation , 2011, Biochemistry (Moscow).

[9]  I. Pérez-Torres,et al.  Sex steroid hormones, cardiovascular diseases and the metabolic syndrome. , 2011, Cardiovascular & hematological agents in medicinal chemistry.

[10]  G. Hansson,et al.  The immune system in atherosclerosis , 2011, Nature Immunology.

[11]  J. Schwabe,et al.  Negative regulation by nuclear receptors: a plethora of mechanisms , 2011, Trends in Endocrinology & Metabolism.

[12]  A. Villablanca,et al.  Atherosclerosis and sex hormones: current concepts. , 2010, Clinical science.

[13]  A. N. Smirnov.  Lipid signaling in the atherogenesis context , 2010, Biochemistry (Moscow).

[14]  D. Lambright,et al.  Structural basis for Rab GTPase recognition and endosome tethering by the C2H2 zinc finger of Early Endosomal Autoantigen 1 (EEA1) , 2010, Proceedings of the National Academy of Sciences.

[15]  P. Chedraui,et al.  Review: Gender Differences in Cardiovascular Disease: Hormonal and Biochemical Influences , 2010, Reproductive sciences.

[16]  Mishra Ashwini,et al.  初期エンドソーム自己抗原1(EEA1)のC2H2亜鉛フィンガーによるRab GTPアーゼ認識とエンドソーム繋留の構造基盤 , 2010 .

[17]  Razzhevaĭkin Vn,et al.  The evolutionary optimality principle as a tool to model structured biological systems , 2010 .

[18]  B. Fagerberg,et al.  Expression of chemokine (C-C motif) ligand 18 in human macrophages and atherosclerotic plaques. , 2009, Atherosclerosis.

[19]  M. H. Friedman,et al.  In vivo differences between endothelial transcriptional profiles of coronary and iliac arteries revealed by microarray analysis. , 2008, American journal of physiology. Heart and circulatory physiology.

[20]  A. Orekhov,et al.  Comparative contents of mRNAs of sex steroid receptors and enzymes of their metabolism in arterial walls of men , 2008, Biochemistry (Moscow).

[21]  M. Daemen,et al.  Dead or alive: gene expression profiles of advanced atherosclerotic plaques from autopsy and surgery. , 2007, Physiological genomics.

[22]  R. Abboud,et al.  Stability of housekeeping genes in alveolar macrophages from COPD patients , 2006, European Respiratory Journal.

[23]  V. Miller,et al.  Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease. , 2005, The Journal of clinical endocrinology and metabolism.

[24]  C. Higgins,et al.  ABCA1 Expression in Carotid Atherosclerotic Plaques , 2004, Stroke.

[25]  T. Ishibashi,et al.  Steroid sulfatase and estrogen sulfotransferase in the atherosclerotic human aorta. , 2003, The American journal of pathology.

[26]  G. Hansson,et al.  Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation , 2002, Circulation.

[27]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Circulation.

[28]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Circulation.